AstraZeneca's efforts to delist its Indian arm suffered another jolt after the Bombay High Court granted an interim stay on the proposed plan following objections raised by certain minority shareholders.
The minority shareholders served a petition on 3 July on the parent company AstraZeneca Pharmaceuticals AB, AstraZeneca Pharma India and...